“Increasing cases of Pneumonia will cause Developing Regions of the world to be the major contributors of Pneumococcal Vaccines Industry”, says RNCOS.
Noida, UP -- (SBWIRE) -- 08/21/2015 -- The cases of pneumonia and diarrhea have been on a rise in specific countries of the world which belong to the developing regions. These countries include India, China, Japan, etc. These countries accounted for 71% of the child deaths from these two diseases. The main reason for this could be the lack of availability of proper medication and hygienic living conditions. But this scenario is changing as people are becoming aware of about personal hygiene as well as the medication and vaccines for pneumonia and diarrhea. The key players in the Pneumococcal Vaccine Industry are GSK, Pfizer and Merck. These companies have started to receive a large share of revenue from the developing regions which was around 18% in 2014. Observing the current trend, this share will continue to increase in the coming years.
According to our report, "Global Pneumonia Vaccine Market Outlook 2020", the Pneumonia vaccine market for 2014, which has been estimated at US$ 5.9 Billion, is expected to reach US$ 11 Billion by 2020, growing at a CAGR of 11.1% over the six year period. The report offers a clear and succinct take on the current Pneumococcal Vaccine Industry. The regional distribution of the current market has also been discussed.
As vaccines are highly regulated to ensure patients and users have access to safe and effective medicines, the regulatory scenarios for vaccine approval and licensing has also been discussed. It has been noted that individual governments determine which products can be marketed in their countries and many have state-regulated systems governing product pricing.
Lastly, the report talks of the three major players of the industry, GlaxoSmithKline, Pfizer and Merck. The competitive landscape is supplemented with a chapter highlghting the current share of every player in the market. This is followed by company profiles, wherein the general business alongwith the key finanacials of every player have been provided. At the end of every profile, a strength weakness analysis has been performed. The report provides a prudent analysis of the market and is a must have supplement for any player interested in the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM764.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.